Resumen de FDA Lifts Restrictions on Rosiglitazone
* The Food and Drug Administration has lifted many of the restrictions it had placed on the type 2 antidiabetic drug rosiglitazone (Avandia) in 2011.
* Reevaluation of data from a major clinical trial indicated that rosiglitazone did not increase the risk of cardiovascular events as had been previously suggested.
